Regulatory T Cells Orchestrate Similar Immune Evasion of Fetuses and Tumors in Mice

• Published in: The Journal of immunology (1950) 2016-01, Vol.196 (2), p.678-690
• Main Authors: Nehar-Belaid, Djamel, Courau, Tristan, Dérian, Nicolas, Florez, Laura, Ruocco, Maria Grazia, Klatzmann, David
• Format: Article
• Language: English
• Subjects: Animals; Female; Fetal Development - immunology; Fetus - immunology; Human health and pathology; Immune Tolerance - immunology; Life Sciences; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms - immunology; T-Lymphocytes, Regulatory - immunology; Transcriptome; Tumor Escape - immunology
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.1501834

Embryos and tumors are both masses of dividing cells expressing foreign Ags, but they are not rejected by the immune system. We hypothesized that similar tolerogenic mechanisms prevent their rejection. Global comparison of fetal and tumor microenvironments through transcriptomics in mice revealed strikingly similar and dramatic decreases in expression of numerous immune-related pathways, including Ag presentation and T cell signaling. Unsupervised analyses highlighted the parallel kinetics and similarities of immune signature downregulation, from the very first days after tumor or embryo implantation. Besides upregulated signatures related to cell proliferation, the only significant signatures shared by the two conditions across all biological processes and all time points studied were downmodulated immune response signatures. Regulatory T cell depletion completely reverses this immune downmodulation to an immune upregulation that leads to fetal or tumor immune rejection. We propose that evolutionarily selected mechanisms that protect mammalian fetuses from immune attack are hijacked to license tumor development.